You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 127 No. 1, January 2009 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Letters
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Related letter
 •Similar articles in this journal
 Topic Collections
 •Glaucoma
 •Uveitis
 •Ophthalmological Disorders, Other
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

COMMENTS AND OPINIONS
Uveitis Treated With Fluocinolone Acetonide Implants—Reply

Debra A. Goldstein, MD; David G. Godfrey, MD; Anthony Hall, MD; David G. Callanan, MD; Glenn J. Jaffe, MD; P. Andrew Pearson, MD; Dale W. Usner, PhD; Timothy L. Comstock, OD

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In reply

We appreciate the comments regarding our article1 on IOP in patients treated with a fluocinolone acetonide implant. The authors suggest that laser trabeculoplasty might be a better treatment option than incisional glaucoma surgery in patients with treatment-resistant elevation of IOP after treatment with the steroid implant. We read their article2 with interest, but do not feel that their results can be generalized to the patients with uveitis treated with a fluocinolone implant. They report argon laser trabeculoplasty (ALT) outcomes for 2 patients with elevation of IOP in response to intravitreal triamcinolone.2 The results were encouraging, but neither patient had underlying uveitis, and follow-up was only 2 months in both cases. Because patients with uveitis have traditionally not . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

{omega}-3 Long-Chain Polyunsaturated Fatty Acid Intake Inversely Associated With 12-Year Progression to Advanced Age-Related Macular Degeneration
John Paul SanGiovanni, Elvira Agrón, Traci E. Clemons, and Emily Y. Chew
Arch Ophthalmol. 2009;127(1):110-112.
EXTRACT | FULL TEXT  

Intraocular Pressure in Patients With Uveitis Treated With Fluocinolone Acetonide Implants
Debra A. Goldstein, David G. Godfrey, Anthony Hall, David G. Callanan, Glenn J. Jaffe, P. Andrew Pearson, Dale W. Usner, and Timothy L. Comstock
Arch Ophthalmol. 2007;125(11):1478-1485.
ABSTRACT | FULL TEXT  

RELATED LETTER

Uveitis Treated With Fluocinolone Acetonide Implants
Francesco Viola, Giovanni Staurenghi, and Roberto Ratiglia
Arch Ophthalmol. 2009;127(1):115-116.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.